dimanche 19 janvier 2014

The P1D1 Gene In Relation To Brain Cancer

By Rob Sutter


When talking about brain cancer on the whole, the P1D1 gene is one idea that is more than worth considering. Typically, it is put to use in order to send insulin throughout the body while regulating it, in addition to providing mitochondrial function. This gene has been focused on in studies before but it seems like they have been more rooted in ideas like obesity and diabetes more so than anything else. Can the same be said about this particular type of cancer as well?

I do not think that it is totally surprising to see how this gene can play into brain cancer efforts in the long term. After all, therapies have been put together in the past and it's not uncommon for them to utilize certain aspects that might have been linked to conditions outside of this one. However, when considering that there is a chance for them to come into play here, it's an idea that can draw the attention of organizations along the lines of Voices against Brain Cancer. What is it that can be said about the integral nature of P1D1, though?

Business Wire posted a report that spoke about the level of messenger RNA that has been linked to the P1D1 gene. More specifically, it seems like this has been focused on when looking at the more serious conditions such as medulloblastomas and gliomas. The P1D1 is utilized in order to inhibit cell growth with these types of cancer. With this information, a study was conducted and it seems as though both children and adults with these ailments have been helped through use of a study with intricacy tied in.

When it comes to the therapy and its accompanying results, it probably goes without saying that higher levels of P1D1 mRNA can actually play into the survival rates of patients at large. Keep in mind that, when seen in great amounts, P1D1 can actually work well to kill tumor cells and stop the level of proliferation that would typically occur with these cells. The article mentioned how the study examined adults, seeing as how their survival rates have gone up tremendously. To say the least, this particular gene calls for attention.

It seems as though these therapies possess great potential, meaning that results are more than worth the attention they can bring. This is especially true when considering the detrimental nature that this condition has entailed. It goes without saying that many individuals have been impacted by it, so it also goes without saying that surgery on its own may not create the greatest long-term results. This may be case where focusing on the P1D1 gene is a strong idea.




About the Author:



Aucun commentaire:

Enregistrer un commentaire